Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lymphocyte-mediated cytotoxicity.

John H Russell1, Timothy J Ley

  • 1Department of Molecular Biology and Pharmacology, Washington University School of Medicine, St. Louis, Missouri 63110, USA. jrussell@pcg.wustl.edu

Annual Review of Immunology
|February 28, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-read cDNA sequencing reveals novel isoforms and spliceosome-mutant-enriched transcripts in AML and MDS.

bioRxiv : the preprint server for biology·2026
Same author

Corrigendum to "Recurrent Transcriptional Responses in AML and MDS patients Treated with Decitabine" Experimental Hematology. 2022;111:50-65.

Experimental hematology·2026
Same author

Evaluation of Long-Read Genome Sequencing for Genomic Profiling of Myeloid Cancers.

The Journal of molecular diagnostics : JMD·2025
Same author

Overexpression of the signaling coordinator GAB2 can play an important role in acute myeloid leukemia progression.

The Journal of clinical investigation·2025
Same author

Genomic selection in western redcedar: from proof of concept to operational application.

The New phytologist·2024
Same author

PML::RARA and GATA2 proteins interact via DNA templates to induce aberrant self-renewal in mouse and human hematopoietic cells.

Proceedings of the National Academy of Sciences of the United States of America·2024

Cell-mediated cytotoxicity relies on granule exocytosis and Fas pathways. Understanding their interplay is key for treating autoimmune diseases and graft-versus-host disease, while balancing immune function.

Area of Science:

  • Immunology
  • Cell Biology

Background:

  • Cell-mediated cytotoxicity is crucial for immune surveillance and is primarily mediated by cytotoxic T lymphocytes and natural killer cells.
  • Two main pathways, granule exocytosis and Fas/FasL, are responsible for delivering cytotoxic signals to target cells.
  • Granzyme A and B, delivered via granule exocytosis, induce apoptosis through distinct mechanisms, while the Fas/FasL system mediates activation-induced cell death and lymphocyte killing.

Purpose of the Study:

  • To elucidate the distinct roles and interplay of the granule exocytosis and Fas pathways in cell-mediated cytotoxicity.
  • To explore the therapeutic potential of modulating these pathways for autoimmune and graft-versus-host diseases.
  • To highlight the risks of pathway oversuppression, including increased susceptibility to viral infections and impaired tumor immunity.

Related Experiment Videos

Main Methods:

  • The abstract does not specify methods, but implies analysis of cytotoxic mechanisms.
  • Focus on the molecular effectors: perforin, granzymes, and Fas/FasL.
  • Examination of the functional outcomes: apoptosis induction, DNA fragmentation, and immune regulation.

Main Results:

  • Granule exocytosis and Fas pathways are the primary contributors to measurable cell-mediated cytotoxicity.
  • Granzyme A and B initiate apoptosis via independent pathways, while Fas/FasL mediates specific cell death contexts.
  • The combined action of these pathways offers therapeutic targets but also presents risks if dysregulated.

Conclusions:

  • Targeting the interplay between granule exocytosis and Fas pathways holds promise for managing autoimmune and graft-versus-host diseases.
  • Careful modulation is necessary to avoid detrimental effects such as increased viral susceptibility or reduced anti-tumor immunity.
  • Further research into these cytotoxic mechanisms can inform novel immunotherapeutic strategies.